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Pericardial and polytetrafluoroethylene patches are
currently the most commonly used materials for intraven-
tricular repair but are limited by calcification and retraction.
The extracellular matrix (ECM) biomaterial CorMatrix
ECM (CorMatrix Cardiovascular, Inc, Roswell, Ga) is an
absorbable tissue scaffold synthesized from decellularized
porcine small intestinal submucosa that is rich in collagen,
glycosaminoglycans, and growth factors. Furthermore,
in experimental models of myocardial infarction and
ventricular repair, ECM patches have been shown to
stimulate infiltration of cells, including cardiomyocytes,
as well as ECM production.1,2
The epicardial application of CorMatrix ECM has been
demonstrated to decrease infarct size and scar formation
after myocardial infarction.3 We have previously studied
the operative safety of the use of CorMatrix ECM for
left ventricular aneurysm repair and ventricular septal
defect repairs, with no primary repair failures.4 Here we
report a case of ventricular false aneurysm repair withCorMatrix ECM, which resulted in improvement of ven-
tricular contractile activity at 1-year follow-up.CLINICAL SUMMARY
A75-year-old female patient underwent 3-vessel coronary
artery bypass grafting 9 years before the index visit, then 3
years before the index visit had an acute infarction with
ventricular rupture. She underwent sutureless repair of a
false aneurysm with Bioglue (CryoLife, Inc, Kennesaw,
Ga) closure of the lateral ventricular wall.
The patient reported chest pain and syncope. Angiog-
raphy revealed a superficial false aneurysm (54 3 24 mm)
superimposed on a deeper false aneurysm (72 3 49 mm;
Figure 1, A, and Video 1). Transthoracic echocardiography
demonstrated inferior and inferolateral hypokinesis of
the left ventricle (left ventricular ejection fraction
20%-40%), ventricular dilation (left ventricular end-
systolic diameter 39 mm and left ventricular end-diastolic
diameter 53 mm), mild mitral regurgitation, and large false
aneurysms.
The patient underwent CorMatrix ECM false aneurysm
repair with femoral cannulation through a left thoracotomy.
The false aneurysm was opened under deep hypothermic
circulatory arrest (28C). The communication between the
superficial and deep false aneurysm was approximately
203 20 mm, and the more recent false aneurysm was filled
with thrombus. The neck of the old false aneurysm extend-
ing from the base of the papillary muscles to the apex was
closedwithCorMatrix ECMwith running 4-0monofilament
suture. The superficial false aneurysm was then closed.
The patient was rewarmed and decannulated.
Immediate postoperative echocardiography demon-
strated inferolateral and anterolateral mid-to-apical akinesis
of the left ventricle (left ventricular ejection fraction
35%-45%, left ventricular end-systolic diameter 35 mm,
left ventricular end-diastolic diameter 42 mm; Figure 1, Brdiovascular Surgery c Volume 147, Number 4 e41
FIGURE 1. Images of CorMatrix ECM intraventricular repair. A, Preoperative angiography demonstrating contrast into the neck of an initial false aneurysm
(arrows) and a superimposed false aneurysm (arrowheads). B and C, Postoperative transesophageal echocardiography shows the noncontractile CorMatrix
ECMpatch (bordered by arrows) in diastole (B) and systole (C). D and E, Transesophageal echocardiograph at 1-year follow-up shows a contractile posterior
left ventricular wall in the area of previous CorMatrix ECM patch repair (bordered by arrows) in diastole (C) and systole (D).
Case Reportsand C, and Video 2). There was no aneurysm and no patch
leak. The patient was discharged from the hospital on
postoperative day 10.
At 1 year, the patient had returned to her baseline func-
tion without any limitations. Transthoracic echocardiogra-
phy demonstrated preserved left ventricular end-systolic
diameter (36 mm) and left ventricular end-diastolic
diameter (44 mm) and, to our surprise, restoration of left
ventricular function (left ventricular ejection fraction
>60%). Furthermore, the area of the CorMatrix ECM patch
appeared to have increased wall thickness and synchronous
contractile activity (Figure 1, D and E, and Video 3).e42 The Journal of Thoracic and Cardiovascular SurgDISCUSSION
This is the first clinical report to demonstrate an increase in
myocardial wall thickness and ventricular contractile activity
with the use of CorMatrix ECM and to document associated
clinical improvement. The use of Dacron polyester fabric
patch for ventricular aneurysm repair has been associated
with early improvement in ventricular function (left ventric-
ular ejection fraction from 28% to 39%; P¼ .007).5 Gener-
ation of myocardial wall thickness and improvement in
systolic function, however, have not previously been shown.
As mentioned, several experimental studies have demon-
strated cellular regeneration with ECM deposition withinery c April 2014
Case Reportssmall intestinal submucosa ECMgrafts.1-2 Althoughwe have
not shown cellular regeneration, our findings of contractile
activity support the continued use and study of CorMatrix
ECM cardiac repair.
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Thorac Surg. 1995;59:403-7.Staged total aortic hybrid repair for DeBakey type I dissection:
Report of a caseMarco Di Eusanio, MD, PhD, Paolo Berretta, MD, Luigi Lovato, MD, and Roberto Di Bartolomeo, MD,
Bologna, ItalyOpen surgical repair for extensive aortic disease represents
a great challenge, and staged approaches involving multiple
hybrid procedures have emerged as an appealing alternative
to conventional open repair.1 We report a case of DeBakey
type I aortic dissection treated with a total aortic repair
through a staged hybrid approach.CLINICAL SUMMARY
A 45-year-old man who had undergone a Bentall proce-
dure for an acute DeBakey type I aortic dissection
(Figure 1, A-C) 7 years previously was referred to our insti-
tution. Computed tomographic scan (Figure 1, D-F) docu-
mented a chronic postdissection aneurysm of the aortic
arch and thoracoabdominal aorta (70 mm) with proximal
entry tears at the brachiocephalic trunk and aortic isthmus.
At the descending thoracic aorta, the true lumen was nar-
row (4 mm) and circumferentially dissected; multiple
reentry tears were located in the distal aorta, and all
visceral vessels originated from the true lumen except for
the right renal artery. A staged hybrid approach was
offered. The patient initially underwent a complete arch
replacement with a wide fenestration of the descending
intimal flap and elephant trunk construction. The arch ves-
sels were reimplanted by means of the separate grafttechnique with a 28-mm Siena 4-branched aortic graft
(Vascutek Ltd, Glasgow, Scotland; Figure 1, G-I). Ante-
grade selective cerebral perfusion with moderate hypother-
mia was used for cerebral protection.2 Two months later,
graft replacement (28 mm) of the descending thoracic aorta
was performed with temporary left heart bypass, sequential
clamping, and cerebrospinal fluid drainage for spinal and
visceral protection (Figure 1, J-L). Four months later, the
patient was readmitted for treatment completion of the re-
sidual thoracoabdominal aortic aneurysm. Through a me-
dian laparotomy with a transperitoneal approach, the
infrarenal abdominal aorta was replaced and the visceral
vessels were revascularized with a 28-mm multi-
branched Coselli thoracoabdominal graft (Vascutek). Se-
lective renal perfusion with cold crystalloid solution was
used for renal protection (Figure 2, A-D). During the
same hospitalization, endovascular exclusion of the re-
maining thoracoabdominal aorta was then performed; 2
Valiant Medtronic stent-grafts (34-36 mm) were implanted
with a 20% to 30% oversizing. Graft-to-graft overlaps of 4
and 3 cm were achieved in the proximal and distal landing
zones, respectively. Cerebrospinal fluid drainage was
applied for spinal cord protection. The predischarge
computed tomographic scan showed a total aortic replace-
ment with a partially thrombosed false lumen as a result of
residual endograft porosity (Figure 2, E-H). All postopera-
tive courses were totally uneventful. At 6-month follow-up,
the patient remains well, with unchanged aortic appear-
ances and stable aortic diameters.DISCUSSION
Reoperations for extensive open aortic replacement are
associated with considerable morbidity and mortality. Dur-
ing the last decades, hybrid and endovascular repairrdiovascular Surgery c Volume 147, Number 4 e43
